Endotoxin significantly contaminates house dust and is an enhancing factor for asthma severity. Natural exposure to endotoxin in early life could influence immune development and protect from the risk of developing atopy. This article will focus on published data showing that home environmental contamination by endotoxin can participate in chronic airways diseases, in particular asthma.
References
1.
Rylander R.Endotoxins in the environment: a criteria document. Int J Occup Environ Health1997; 3 (Suppl. 1): S1-S4.
2.
Pernis B., Vigliani EC, Cavagna C., Finulli M.The role of bacterial endotoxins in occupational diseases caused by inhaling vegetable dusts. Br J Ind Med1961; 18: 120.
3.
Tuypens E.Byssinosis among cotton workers in Belgium. Br J Ind Med1961; 18: 117-119.
4.
Meir R., Bein J., Jacques R.The action of bacterial polysaccharides on allergic phenomena. Int Arch Allergy1957; 11: 101.
5.
Peterson Rda, Wicklund PE, Good RAEndotoxin activity of a house dust extract. J Allergy1964; 35: 134-142.
6.
Cavagna G., Foa V., Vigliani ECEffects in man and rabbits of inhalation of cotton dusts or extracts and purified endotoxin. Br J Ind Med1969; 26: 314-321.
7.
Voorhorst R., Spieksma ThM, Varekamp H, Leupen MJ, Lyklema AW. The house dust mite (Dermatophagoides pteronyssinus) and the allergens it produces. Identity with the house-dust allergen. J Allergy1967; 39: 325-339.
8.
Siraganian RP , Baer H., Hochstein HD, May JCAllergenic and biological activity of commercial preparations of house dust extract. J Allergy Clin Immunol1979; 64: 526-533.
9.
van der Zwan JC, Orie NG, Kauffman HF, Wiers Pwj, De Vries K.Bronchial obstructive reactions after inhalation with endotoxin and precipitinogens of Haemophilus influenzae in patients with chronic non-specific lung disease. Clin Allergy1982; 12: 547-559.
10.
Castellan RM , Olenchock SA, Kinsley KB, Hankinson JLInhaled endotoxin and decreased spirometric values. N Engl J Med1987; 317: 605-610.
11.
Thelin A., Tegler O., Rylander R.Lung reaction during poultry handling related to dust and bacterial endotoxin levels. Eur J Respir Dis1984; 65: 266-271.
12.
Rylander R. , Haglind P., Lundholm M.Endotoxin in cotton dust and respiratory function decrement among cotton workers in an experimental cardroom. Am Rev Respir Dis1985; 131: 209-213.
13.
Castellan RM , Olenchok SA, Hankinson JL et al. Acute bronchoconstriction induced by cotton dust: dose-related response to endotoxin and other dust factors. Ann Intern Med1984; 101: 157-163.
14.
Rylander R. , Haglind P.Airborne endotoxins and humidifier disease . Clin Allergy1984; 14: 109-112.
15.
Donham KJ, Haglind P., Peterson Y., Rylander R., Belin L.Environmental and health studies of farm workers in Swedish swine confinement buildings. Br J Ind Med1989; 46: 31-37.
16.
Muittari A. , Rylander R., Salkinoja-Salonen N.Endotoxin and bath-water fever. Lancet1980; 2: 89.
17.
Flaherty DK , Deck FH, Cooper J. et al. Bacterial endotoxin isolated from a water spray air humidification system as a putative agent of occupation-related lung disease. Infect Immun1984; 43: 206-212.
18.
Burge PS, Finnegan M., Horsfield N. et al. Occupational asthma in a factory with a contaminated humidifier . Thorax1985; 40: 248-254.
19.
Olenchock SA , May JJ, Pratt DS, Morey PROccupational exposures to airborne endotoxins in agriculture. Prog Clin Biol Res1987; 231: 1475-1487.
20.
Dutkiewitz J., Olenchock SA, Sorenson WG et al. Levels of bacteria, fungi, and endotoxin in bulk and aerosolized corn silage. Appl Environ Microbiol1989; 55: 1093-1099.
21.
Rylander R, Donham KJ, Peterson Y. (eds) Health effects of organic dusts in the farm environment. Am J Ind Med1986; 10: 193-340.
22.
Rylander R, Peterson Y, Ong SG, Liao S. (eds) Byssinosis in the Far East. Am J Ind Med1987; 12: 647-804.
23.
Rylander R, Peterson Y. (eds) Organic dusts and lung disease. Am J Ind Med1990; 17: 1-148.
24.
Evans ASCausation and disease: the Henle-Koch postulates revisited. Yale J Biol Med1976: 49: 175-195.
25.
Rylander R. , Persson K., Goto H., Yuasa K., Tanaka S.Airborne beta-1,3-glucan may be related to symptoms in sick buildings. Indoor Environ1992; 1: 263-267.
26.
Michel O., Ginnani R., Duchateau J., Vertongen F., Le Bon B., Sergysels R.Domestic endotoxin exposure and clinical severity of asthma. Clin Exp Allergy1991; 21: 441-448.
27.
Preller L., HeederikD, Boleij JS, Vogelzang PF, Tielen MJ. Lung function and chronic respiratory symptoms of pig farmers: focus on exposure to endotoxins and ammonia and use of disinfectants. Occup Environ Med1995; 52: 654-660.
28.
Michel O., Kips J., Duchateau J. et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med1996; 154: 1641-1646.
29.
Rizzo MC, Naspitz CK, Fernandez-Caldas E., Lockey RF, Mimiç a I, Solé D.Endotoxin exposure and symptoms in asthmatic children. Pediatr Allergy Immunol1997; 8: 121-126.
30.
Douwes J., Zuidhof A., Doekes G. et al. (1-3)-β-D-Glucan and endotoxin in house dust and peak flow variability in children. Am J Respir Crit Care Med2000; 162: 1348-1354.
31.
Wouters IM, Douwes J., Doekes G., Thorne PS, Brunekreef B., Heederik Djj.Increased levels of markers of microbial exposure in homes with indoor storage of organic household waste. Appl Environ Microbiol2000; 66: 627-632.
32.
Gereda JE, Leung Dym, Thatayatikom A. et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma . Lancet2000; 355: 1680-1683.
33.
von Mutius E., Braun-Fahrlander B., Schierl R. et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy2000; 30: 1205-1212.
34.
Park J-H., Gold DR, Spiegelma DL, Burge HA, Milton DKHouse dust endotoxin and wheeze in the first year of life. Am J Respir Crit Care Med2001; 163: 322-328.
35.
Gereda JE, Klinnert MD, Price MR, Leung Dym, Liu AHMetropolitan home living conditions associated with indoor endotoxin levels . J Allergy Clin Immunol2001; 107: 790-796.
36.
Heinrich J. , Gehring U., Douwes J. et al. Pets and vermin are associated with high endotoxin levels in house dust. Clin Exp Allergy2001; 31: 1839-1845.
37.
Franci HC, Fletcher GD, Pickering C., Frank TL, Frank PI, Oldham LAEndotoxin levels higher in asthmatic compared to non asthmatic children in an urban community population [abstract]. J Allergy Clin Immunol2001; 107: S93.
38.
Bishof W., Koch A., Fahlbusch B., Wichman HE, Heinrich J.Predictors of high endotoxin concentrations in the settled dust in German homes. Indoor Air2002; 12: 2-9.
39.
Chun DT, Chew V., Barlett K. et al. Second inter-laboratory study comparing endotoxin assay from cotton dust. Ann Agric Environ Med2002; 9: 49-53.
40.
Hasday JD, Bascom R., Costa JJ, Fitzgerald T., Dubin W.Bacterial endotoxin is an active component of cigarette smoke. Chest1999; 115: 829-835.
41.
Rylander R. , Bake B., Fisher JJ, Helander IMPulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis1989; 140: 981-986.
42.
Michel O., Nagy A-M., Schroeven M. et al. Dose-response relationship to inhaled endotoxin in normal subjects . Am J Respir Crit Care Med1997; 156: 1157-1164.
43.
Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, Schwartz DAGrain dust and endotoxin inhalation challenges produce similar inflammatory response in normal subjects. Chest1996; 110: 263-270.
44.
Milton DK, Amsel J., Reed CE et al. Cross-sectional follow-up of a flu-like respiratory illness among fiberglass manufacturing employees: endotoxin exposure associated with two distinct sequelae. Am J Ind Med1995; 28: 469-488.
45.
Larsson KA, Eklund AG, Hansson LO, Isaksson BM, Malmberg POSwine dust causes intense airways inflammation in healthy subjects. Am J Respir Crit Care Med1994; 150: 973-977.
46.
Michel O., Dentener M., Corazza F., Buurman W., Rylander R.Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. J Allergy Clin Immunol2001; 107: 797-804.
47.
Kline JN, Cowden J., Hunninghake GW et al. Variable airway responsiveness to inhaled lipopolysaccharide . Am J Respir Crit Care Med1999; 160: 297-303.
48.
Michel O., Duchateau J., Sergysels R.Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol1989; 66: 1059-1064.
49.
Michel O., Ginanni R., Le Bon B., Content J., Duchateau J., Sergysels R.Inflammatory response to acute inhalation of endotoxin in asthmatic patients . Am Rev Respir Dis1992; 146: 352-357.
50.
Herbert A., Carvalheiro M., Rubenowitz E., Bake B., Rylander R.Reduction of alveolar-capillary diffusion after inhalation of endotoxin in normal subjects. Chest1992; 102: 1095-1098.
51.
Michel O., Duchateau J., Plat G. et al. Blood inflammatory response to inhaled endotoxin in normal subjects . Clin Exp Allergy1995; 25: 73-79.
52.
Moreland JG , Fuhrman RM, Wohlford-Lenane CL et al. TNF-alpha and IL-1 beta are not essential to the inflammatory response in LPS-induced airway disease. Am J Physiol2001; 280: L173-L180.
53.
Hunt LW, Gleich GJ, Ohnishi T. et al. Endotoxin contamination causes neutrophilia following pulmonary allergen challenge. Am J Respir Crit Care Med1994; 149: 1471-1475.
54.
Clapp WD, Becker S., Quay J. et al. Grain dust-induced airflow obstruction and inflammation of the lower respiratory tract. Am J Respir Crit Care Med1994; 150: 611-617.
55.
O'Grady NP, Praes HL, Pugin J. et al. Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med2001; 163: 1591-1598.
56.
Sandstrom T. , Bjermer L., Rylander R.Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid. Eur Respir J1992; 5: 992-996.
57.
Thorn J., Rylander R.Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique. Thorax1998; 53: 1047-1052.
58.
Nightingale JA, Rogers DF, Hart LA, Kharitonov SA, Chung KF, Barnes PJEffect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects. Thorax1998; 53: 563-571.
59.
Drouin SM, Kildsgaard J., Haviland J. et al. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma . J Immunol2001; 166: 2025-2032.
60.
Michel O., Dentener M., Cataldo D. et al. Effects of oral Prednisolone and Cilomilast on LPS-induced inflammation in human. 2002; Submitted.
61.
Peden DB, Tucker K., Murphy P. et al. Eosinophil influx to the nasal airway after low-level LPS challenge in humans. J Allergy Clin Immunol1999; 104: 388-394.
62.
Meerschaert J., Busse WW, Bertics PJ, Mosher DFCD14(+) cells are necessary for increased survival of eosinophils in response to lipopolysaccharide. Am J Respir Cell Mol Biol2000; 23: 780-787.
63.
Allenby MI, Lethridge MW, Ketchell RI et al. The changes in airway inflammatory cells following inhalation of lipopolysaccharide (LPS). J Allergy Clin Immunol2002; 109: A35.
64.
Dubin W., Martin TR, Swoveland P. et al. Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol1996; 270: L736-L744.
65.
Michel O., Ginanni R., Sergysels R.Relation between the bronchial obstructive response to inhaled lipopolysaccharide and bronchial responsiveness to histamine. Thorax1992; 47: 288-291.
66.
Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., Koga Y.The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol1997; 159: 1739-1745.
67.
Martinez FDMaturation of immune responses at the beginning of asthma. J Allergy Clin Immunol1999; 103: 355-361.
68.
Holt PG, Sly PD, Bjö rksté n B. Atopic versus infectious diseases in childhood: a question of balance?Pediatr Allergy Immunol1997; 8: 53-58.
69.
Liu AH, Leung DYModulating the early allergic response with endotoxin. Clin Exp Allergy2000; 30: 1535-1539.
70.
Poltorak A. , He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085-2088.
71.
Baldini M., Lohman IC, Halonen M., Erickson RP, Holt PG, Martinez FDA polymorphism in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol1999; 20: 976-983.
72.
Koppelman GH , Reijmerink NE, Stine OC et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med2001; 163: 965-969.
73.
Arbour NC, Lorenz E., Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet2000; 25: 187-191.
74.
Michel O., Le Van T., Dentener M. et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the Toll-like receptor 4 gene in humans. J Allergy Clin Immunol2003, In Press.
75.
Raby BA, Klimecki WT, Laprise C. et al. Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med2002; 166: 1449-1456.
76.
Tulic MK, Wale JL, Holt PG, Sly PDModification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol2000; 22: 604-612.
77.
Boehlecke BA , Peden D., Hazucha M., Alexis N., Tucker K., Bromberg P.Exposure to low level of endotoxin for four hours increased response to inhaled mite allergen in mild asthmatics [abstract] . Am J Respir Crit Care Med1999; 159: A699.
Garty BZ, Monselise Y., Nitzan M.Soluble CD14 in children with status asthmaticus. Isr Med Assoc J2000; 2: 104-107.
80.
Vernoy Jhj, Dentener MA, van Suylen RJ, Buurman, Wouters EFM. Long-term intratracheal LPS exposure results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol2002; 26: 152-159.
81.
Milton DK, Godleski JJ, Feldman HA, Greaves IAToxicity of intratracheal instilled cotton dust, cellulose, and endotoxin . Am Rev Respir Dis1990; 142: 184-192.
82.
Gunter CA, Coalsen JJ, Jacques J.Emphysema associated with intravascular leukocyte sequestration. Comparison with papain-induced emphysema. Am Rev Respir Dis1981; 123: 79-84.
83.
Blackwood RA , Cantor JO, Moret J., Mandl I., Turino GMGlycosaminoglycan synthesis in endotoxin-induced lung injury. Proc Soc Exp Biol Med1983; 174: 343-349.
84.
Rudolphus A., Stolk J., Dijkman JH, Kramps JAInhibition of LPS-induced pulmonary emphysema by intratracheally instilled recombinant secretory leukocyte proteinase inhibitor. Am Rev Respir Dis1993; 147: 442-447.
85.
Vogelzang Pfj , van der Gulden JWJ, Folgering H. et al. Endotoxin exposure as a major determinant of lung function decline in pig farmers. Am J Respir Crit Care Med1998; 157: 15-18.
86.
Zock J-P., Heederik B., Brunekreef B.Influence of shift work and host factors on endotoxin-related acute peak flow changes. Am J Respir Crit Care Med1999; 159: 37-42.
87.
Von Essen S.The role of endotoxin in grain dust exposure and airway obstruction. Curr Opin Pulm Med1997; 3: 198-202.
Rylander R., Malmberg P.Non-infectious fever. Inhalation fever or toxic alveolitis. Br J Ind Med1992; 49: 296.
90.
Milton DK, Amsel J., Reed CE et al. Cross-sectional follow-up of a flu-like respiratory illness among fiberglass manufacturing employees: endotoxin exposure associated with two distinct sequelae. Am J Ind Med1995; 28: 469-488.
91.
Milton DK, Rose CS, Martiny JW, Kreiss K.Airborne endotoxin associated with hypersensitivity pneumonitis outbreak among lifeguards [abstract]. Am Rev Respir Dis1990 ; 141: A31544.
92.
Neal PA, Schneiter R., Caminita BHReport on acute illness among rural mattress makers using low grade stained cotton. JAMA1942; 140: 1074-1082.
93.
Zhiping W., Malmberg P., Larsson BM, Larsson K., Larsson L., Sarafa A.Exposure to bacteria in swine house dust and acute inflammatory reaction in humans. Am J Respir Crit Care Med1996; 154: 1261-1266.
94.
Verhasselt V., Buelens C., Willems F., De Groote D, Haeffner-Cavaillon N., Goldman M.Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells. J Immunol1997; 158: 2919-2925.
95.
Macatonia SE , Hoskin NA, Litton M. et al. Dendritic cells produce IL-12 and direct the development of Th-1 cells from naï ve to CD+4T cells. J Immunol1995; 154: 5071-5079.
96.
Martinez FDMaturation of immune responses at the beginning of asthma. J Allergy Clin Immunol1999; 103: 355-361.
97.
Holt PG, Sly PD, Bjö rksté n B. Atopic versus infectious diseases in childhood: a question of balance?Pediatr Allergy Immunol1997; 8: 53-58.
98.
Reed CE, Milton DKEndotoxin-stimulated innate immunity: a contributing factor for asthma. J Allergy Clin Immunol2001; 108: 157-166.
99.
Liu AHEndotoxin exposure in allergy and asthma: reconciling a paradox. Allergy Clin Immunol2002; 109: 379-392.
100.
Gehring U. , Bolte G., Borte M. et al Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study. J Allergy Clin Immunol2001; 108: 847-854.
101.
Gehring U. , Bischof W., Fahlbusch B., Wichmann HE, Heinrich J.House dust endotoxin and allergic sensitization in children. Am J Respir Crit Care Med2002 ; 166: 939-944.
102.
Braun-Fahrlander C., Riedler J., Herz U. et al. and Allergy and Endotoxin Study Team. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med2002; 347: 869-877.
103.
Cochran JR , Khan AM, Elidemir O. et al. Influence of lipopolysaccharide exposure on airway function and allergic responses in developing mice. Pediatr Pulm2002; 34: 267-277.
104.
Wan GH, Li CS, Lin RHAirborne endotoxin exposure and the development of airway antigen-specific allergic responses. Clin Exp Allergy2000; 30: 426-432.
105.
Michel O., Ginanni R., Sergysels R.Protective effect of sodium cromoglycate on lipopolysaccharide-induced bronchial obstruction in asthmatics. Int Arch Allergy Immunol1995; 108; 298-302.
106.
Michel O., Olbrecht J., Moulard D., Sergysels R.Effect of antiasthmatic drugs on the response to inhaled endotoxin. Ann Allergy Asthma Immunol2000; 85: 305-310.
107.
Alexis NE, Peden DBBlunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: a role for CD14. J Allergy Clin Immunol2001; 108: 577-580.
108.
Bundschuh DS, Eltze M., Barsig J., Wollin L., Hatzelmann A., Beume R.In vivo efficacy in airway disease models of Roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther2001; 297: 280-290.
109.
Trifilieff A., Walker C., Keller T., Kottirsch G., Neumann U.Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation. Br J Pharmacol2002; 135: 1655-1664.
110.
Bellanti JA , Zeligs BJ, MacDowell-Carneiro AL, Abaci AS, Genuardi JA. Study on the effects of vacuuming on the concentration of dust mite antigen and endotoxin. Ann Allergy Asthma Immunol2000; 84: 249-254.
